National Cancer Institute; Notice of Closed Meetings

 
CONTENT
Federal Register, Volume 84 Issue 241 (Monday, December 16, 2019)
[Federal Register Volume 84, Number 241 (Monday, December 16, 2019)]
[Notices]
[Pages 68465-68466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27003]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
    Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE (P50) III Review.
    Date: January 29-30, 2020.
    Time: 3:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
[[Page 68466]]
    Place: Gaithersburg Marriott Washingtonian Center, 9751
Washington Blvd., Gaithersburg, MD 20878.
    Contact Person: Anita T. Tandle, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W248, Bethesda, MD 20892, 240-276-5085,
[email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project (P01) Review III.
    Date: February 6-7, 2020.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
    Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, National Institutes of Health, Rockville,
MD 20850, 240-276-5864, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP 7: NCI Clinical and Translational R21 and Omnibus R03.
    Date: February 12-13, 2020.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Robert Stephen Coyne, Ph.D., Scientific Review
Officer, National Cancer Institute, NIH, Division of Extramural
Activities, Special Review Branch, 9609 Medical Center Drive, Room
7W236, Rockville, MD 20850, 240-276-5120, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: NCI Clinical and Translational R21 and Omnibus R03.
    Date: February 13-14, 2020.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240, Rockville, MD 20850, 240-276-5122, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-1: SBIR Contract Review.
    Date: February 19-20, 2020.
    Time: 6:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Marriott Bethesda North Hotel & Conference Center, 5701
Marinelli Road, Rockville, MD 20850.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, 9609 Medical Center Drive, Room 7W260,
National Cancer Institute, NIH, Bethesda, MD 20892-9745, 240-276-
5856, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Research Specialist Award R50.
    Date: February 27-28, 2020.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, 7W242,
Bethesda, MD 20892, 240-276-6372, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; Transition to Independence SEP.
    Date: March 10, 2020.
    Time: 10:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, MD 20850 (Telephone Conference
Call).
    Contact Person: Delia Tang, M.D., Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W602, Bethesda, MD 20892, 240-276-6456, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging Methods and Resources (UG3/UH3, U24).
    Date: March 13, 2020.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 6W030, Rockville, MD 20850 (Telephone Conference
Call).
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, MD 20850, 240-276-7684, [email protected].
    Name of Committee: National Cancer Institute Special Emphasis
Panel; HIV-Associated Malignancy Research.
    Date: March 26-27, 2020.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conference Center, 5701
Marinelli Road, Rockville, MD 20852.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, 9609 Medical Center Drive, Room 7W260,
National Cancer Institute, NIH, Bethesda, MD 20892-9745, 240-276-
5856, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
    Dated: December 10, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27003 Filed 12-13-19; 8:45 am]
 BILLING CODE 4140-01-P